<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00709930</url>
  </required_header>
  <id_info>
    <org_study_id>MF-II-01</org_study_id>
    <nct_id>NCT00709930</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Weak Extremely Low Frequency Electromagnetic Fields in Mild and Moderate Essential Hypertension</brief_title>
  <official_title>Randomized Placebo-Controlled Trial of Efficacy and Safety of Weak Extremely Low Frequency Electromagnetic Field in Mild and Moderate Essential Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kyoto University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kyoto University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the efficacy and safety of weak extremely low frequency
      electromagnetic fields (ELF-EMF) in mild and moderate essential hypertension.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">December 2008</completion_date>
  <primary_completion_date type="Actual">August 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The difference between the ELF-EMF and sham groups with respect to the absolute change in SBP value between baseline and the end of the exposure regimen (the age of the pre-exposure values for the last two sessions).</measure>
    <time_frame>baseline and the end of the exposure regimen (the average of the pre-exposure values for the last two sessions)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The difference between the ELF-EMF and sham groups with respect to the change in DBP value between baseline and the end of the exposure regimen (the average of the pre-exposure values for the last two sessions)</measure>
    <time_frame>baseline and the end of the exposure regimen (the average of the pre-exposure values for the last two sessions)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change in both SBP and DBP values between pre-exposure and post-exposure for each session (averaged over the regimen)</measure>
    <time_frame>for each session</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of adverse events</measure>
    <time_frame>during exposure and at the end of the exposure period and at six months after exposure</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Essential Hypertension</condition>
  <arm_group>
    <arm_group_label>1,Exposed to ELF-EMF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Device: Magnetic field generator Exposure to 1-μT 8/6-Hz ELF-EMF</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2,Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Device: Placebo device with no magnetic fields</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Magnetic field generator</intervention_name>
    <description>dosage:Magnetic field generator Exposure to 1-μT 8/6-Hz ELF-EMF frequency:10min/day duration:1 month</description>
    <arm_group_label>1,Exposed to ELF-EMF</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo magnetic field generator</intervention_name>
    <description>Placebo device with no magnetic fields</description>
    <arm_group_label>2,Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages: 20 years to 74 years

          -  Genders : Both

          -  The severity of hypertension: mild and moderate (WHO/ISH criteria stage I-II) Systolic
             blood pressure (SBP) &gt;/= 140 and/or diastolic blood pressure (DBP)&gt;/= 90 (untreated
             hypertension cases)

        Exclusion Criteria:

          -  Any of the following medical conditions:

          -  Severe essential hypertension (DBP &gt;110)

          -  Secondary or malignant hypertension

          -  History or symptoms of cerebral vascular disease

          -  History of myocardial infarction

          -  History of angina pectoris, atrial fibrillation, heart failure and arrhythmia

          -  Renal dysfunction (serum creatinine &gt; 2.1mg/dl)

          -  Severe hepatic dysfunction

          -  Uncontrolled diabetes

          -  Allergy, drug sensitivity or chronic skin disease

          -  Peptic ulcer disease

          -  Current pregnancy or lactation

          -  Depression that needs to be treated

          -  Hypertension controlled with antihypertensive medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Masanori Fukushima</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyoto University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kyoto University Hospital</name>
      <address>
        <city>Kyoto</city>
        <zip>606-8507</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2008</study_first_submitted>
  <study_first_submitted_qc>July 1, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2008</study_first_posted>
  <last_update_submitted>March 30, 2009</last_update_submitted>
  <last_update_submitted_qc>March 30, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 31, 2009</last_update_posted>
  <responsible_party>
    <name_title>Masanori Fukushima</name_title>
    <organization>Translarional Research center</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

